Literature DB >> 32457151

Membrane-tethered mucin-like polypeptides sterically inhibit binding and slow fusion kinetics of influenza A virus.

Corleone S Delaveris1, Elizabeth R Webster1, Steven M Banik1, Steven G Boxer2, Carolyn R Bertozzi2,3.   

Abstract

The mechanism(s) by which cell-tethered mucins modulate infection by influenza A viruses (IAVs) remain an open question. Mucins form both a protective barrier that can block virus binding and recruit IAVs to bind cells via the sialic acids of cell-tethered mucins. To elucidate the molecular role of mucins in flu pathogenesis, we constructed a synthetic glycocalyx to investigate membrane-tethered mucins in the context of IAV binding and fusion. We designed and synthesized lipid-tethered glycopolypeptide mimics of mucins and added them to lipid bilayers, allowing chemical control of length, glycosylation, and surface density of a model glycocalyx. We observed that the mucin mimics undergo a conformational change at high surface densities from a compact to an extended architecture. At high surface densities, asialo mucin mimics inhibited IAV binding to underlying glycolipid receptors, and this density correlated to the mucin mimic's conformational transition. Using a single virus fusion assay, we observed that while fusion of virions bound to vesicles coated with sialylated mucin mimics was possible, the kinetics of fusion was slowed in a mucin density-dependent manner. These data provide a molecular model for a protective mechanism by mucins in IAV infection, and therefore this synthetic glycocalyx provides a useful reductionist model for studying the complex interface of host-pathogen interactions.

Entities:  

Keywords:  glycobiology; influenza A virus; mucin

Year:  2020        PMID: 32457151      PMCID: PMC7293601          DOI: 10.1073/pnas.1921962117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Analysis of kinetic intermediates in single-particle dwell-time distributions.

Authors:  Daniel L Floyd; Stephen C Harrison; Antoine M van Oijen
Journal:  Biophys J       Date:  2010-07-21       Impact factor: 4.033

2.  Highly efficient chemoenzymatic synthesis of naturally occurring and non-natural alpha-2,6-linked sialosides: a P. damsela alpha-2,6-sialyltransferase with extremely flexible donor-substrate specificity.

Authors:  Hai Yu; Shengshu Huang; Harshal Chokhawala; Mingchi Sun; Haojie Zheng; Xi Chen
Journal:  Angew Chem Int Ed Engl       Date:  2006-06-12       Impact factor: 15.336

Review 3.  Structure and function of the cell surface (tethered) mucins.

Authors:  Christine L Hattrup; Sandra J Gendler
Journal:  Annu Rev Physiol       Date:  2008       Impact factor: 19.318

Review 4.  Mucosal physical and chemical innate barriers: Lessons from microbial evasion strategies.

Authors:  Brice Sperandio; Natalie Fischer; Philippe J Sansonetti
Journal:  Semin Immunol       Date:  2015-05-01       Impact factor: 11.130

5.  Mobility-Based Quantification of Multivalent Virus-Receptor Interactions: New Insights Into Influenza A Virus Binding Mode.

Authors:  Matthias Müller; Daniel Lauster; Helen H K Wildenauer; Andreas Herrmann; Stephan Block
Journal:  Nano Lett       Date:  2019-02-13       Impact factor: 11.189

6.  Chemically tunable mucin chimeras assembled on living cells.

Authors:  Jessica R Kramer; Bibiana Onoa; Carlos Bustamante; Carolyn R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-29       Impact factor: 11.205

7.  Measuring distances in supported bilayers by fluorescence interference-contrast microscopy: polymer supports and SNARE proteins.

Authors:  Volker Kiessling; Lukas K Tamm
Journal:  Biophys J       Date:  2003-01       Impact factor: 4.033

8.  Cholesterol enhances influenza binding avidity by controlling nanoscale receptor clustering.

Authors:  I N Goronzy; R J Rawle; S G Boxer; P M Kasson
Journal:  Chem Sci       Date:  2018-01-24       Impact factor: 9.825

9.  Influenza-virus membrane fusion by cooperative fold-back of stochastically induced hemagglutinin intermediates.

Authors:  Tijana Ivanovic; Jason L Choi; Sean P Whelan; Antoine M van Oijen; Stephen C Harrison
Journal:  Elife       Date:  2013-02-19       Impact factor: 8.140

10.  Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion.

Authors:  Jason E Hudak; Stephen M Canham; Carolyn R Bertozzi
Journal:  Nat Chem Biol       Date:  2013-11-24       Impact factor: 15.040

View more
  21 in total

1.  Mucin-mimetic glycan arrays integrating machine learning for analyzing receptor pattern recognition by influenza A viruses.

Authors:  Taryn M Lucas; Chitrak Gupta; Meghan O Altman; Emi Sanchez; Matthew R Naticchia; Pascal Gagneux; Abhishek Singharoy; Kamil Godula
Journal:  Chem       Date:  2021-10-22       Impact factor: 22.804

Review 2.  Roles of Glycans and Non-glycans on the Epithelium and in the Immune System in H1-H18 Influenza A Virus Infections.

Authors:  Nongluk Sriwilaijaroen; Yasuo Suzuki
Journal:  Methods Mol Biol       Date:  2022

3.  Synthetic linear glycopolymers and their biological applications.

Authors:  Qian Qin; Shuyao Lang; Xuefei Huang
Journal:  J Carbohydr Chem       Date:  2021-05-27       Impact factor: 1.667

4.  Modulating the Influenza A Virus-Target Membrane Fusion Interface With Synthetic DNA-Lipid Receptors.

Authors:  Elizabeth R Webster; Katherine N Liu; Robert J Rawle; Steven G Boxer
Journal:  Langmuir       Date:  2022-02-10       Impact factor: 4.331

Review 5.  Mucosal immune responses to infection and vaccination in the respiratory tract.

Authors:  Robert C Mettelman; E Kaitlynn Allen; Paul G Thomas
Journal:  Immunity       Date:  2022-05-10       Impact factor: 43.474

6.  Glycocalyx crowding with mucin mimetics strengthens binding of soluble and virus-associated lectins to host cell glycan receptors.

Authors:  Daniel J Honigfort; Meghan O Altman; Pascal Gagneux; Kamil Godula
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-05       Impact factor: 11.205

Review 7.  The therapeutic potential of sialylated Fc domains of human IgG.

Authors:  Richard J Pleass
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

8.  Modulation of immune cell reactivity with cis-binding Siglec agonists.

Authors:  Corleone S Delaveris; Shannon H Chiu; Nicholas M Riley; Carolyn R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-19       Impact factor: 12.779

9.  Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19.

Authors:  Corleone S Delaveris; Aaron J Wilk; Nicholas M Riley; Jessica C Stark; Samuel S Yang; Angela J Rogers; Thanmayi Ranganath; Kari C Nadeau; Catherine A Blish; Carolyn R Bertozzi
Journal:  ChemRxiv       Date:  2020-12-17

10.  Age-Dependent Glycomic Response to the 2009 Pandemic H1N1 Influenza Virus and Its Association with Disease Severity.

Authors:  Shuhui Chen; Brian Kasper; Bin Zhang; Lauren P Lashua; Ted M Ross; Elodie Ghedin; Lara K Mahal
Journal:  J Proteome Res       Date:  2020-10-05       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.